Clinical trials used up to 1,000mcg/day but research suggests 300500mcg hits the sweet spot for fat mobilization without diminishing returns
Choosing an injection site The most common subcutaneous injection sites for retatrutide are: Abdomen: 2 inches away from the navel, left or right side
At the same time, the decline in obesity rates has been modest so far, with the broader impact of GLP-1 drugs tempered by high costs, uneven access, and the time required for increased adoption to translate into population-level outcomes
To resolve the current controversies regarding the use of GLP-1 RAs in treating hypertension and ischemic cardiomyopathy, large-scale clinical RCTs or real-world studies should be designed to provide more robust evidence
Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit